Association between plasma free haem and incidence of vaso-occlusive episodes and acute chest syndrome in children with sickle cell disease

British Journal of Haematology

Volumn 162, Issue 5, 2013, Pages 702-705

  Adisa, Olufolake A ^a,b   Hu, Yijuan ^c   Ghosh, Samit ^a   Aryee, Doreen ^a   Osunkwo, Ifeyinwa ^a,b   Ofori Acquah, Solomon F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AFLAC   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Acute chest syndrome; Extracellular haem; Sickle cell disease; Vaso occlusive pain crisis

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; HEME; HEMOPEXIN; LACTATE DEHYDROGENASE;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ARTICLE; AVASCULAR NECROSIS; BLOOD VESSEL OCCLUSION; CHILD; FEMALE; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIAPISM; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; VASO-OCCLUSIVE CRISIS;

ACUTE CHEST SYNDROME; EXTRACELLULAR HAEM; SICKLE CELL DISEASE; VASO-OCCLUSIVE PAIN CRISIS;

ACUTE CHEST SYNDROME; ADOLESCENT; ANEMIA, SICKLE CELL; ARTERIAL OCCLUSIVE DISEASES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HEME; HUMANS; MALE;

EID: 84881665543     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12445     Document Type: Article

References (14)

1. Bean, C.J., Boulet, S.L., Ellingsen, D., Pyle, M.E., Barron-Casella, E.A., Casella, J.F., Payne, A.B., Driggers, J., Trau, H.A., Yang, G., Jones, K., Ofori-Acquah, S.F., Hooper, W.C. & Debaun, M.R. (2012) Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood, 120, 3822-3828.
2. Bunn, H.F. & Jandl, J.H. (1968) Exchange of heme among hemoglobins and between hemoglobin and albumin. Journal of Biological Chemistry, 243, 465-475.
3. Bunn, H.F., Nathan, D.G., Dover, G.J., Hebbel, R.P., Platt, O.S., Rosse, W.F. & Ware, R.E. (2010) Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood, 116, 687-692.
4. Castro, O., Brambilla, D.J., Thorington, B., Reindorf, C.A., Scott, R.B., Gillette, P., Vera, J.C. & Levy, P.S. (1994) The acute chest syndrome in sickle cell disease: incidence and risk factors. The cooperative study of sickle cell disease. Blood, 84, 643-649.
5. Ghosh, S. & Ofori-Acquah, S.F. (2010) Acute chest syndrome in transgenic mouse models of sickle cell disease triggered by free heme. Blood, 116, 944.
6. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 886-895.
7. Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G.M., Eaton, J.W. & Balla, G. (2002) Pro-oxidant and cytotoxic effects of circulating heme. Blood, 100, 879-887.
8. Kinney, T.R., Helms, R.W., O' Branski, E.E., Ohene-Frempong, K., Wang, W., Daeschner, C., Vichinsky, E., Redding-Lallinger, R., Gee, B., Platt, O.S. & Ware, R.E. (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric hydroxyurea group. Blood, 94, 1550-1554.
9. Muller-Eberhard, U., Javid, J., Liem, H.H., Hanstein, A. & Hanna, M. (1968) Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood, 32, 811-815.
10. Nouraie, M., Lee, J.S., Zhang, Y., Kanias, T., Zhao, X., Xiong, Z., Oriss, T.B., Zeng, Q., Kato, G.J., Gibbs, J.S., Hildesheim, M.E., Sachdev, V., Barst, R., Machado, R., Hassell, K.L., Little, J.A., Schraufnagel, D.E., Krishnamurti, L., Novelli, E., Girgis, R.E., Morris, C., Rosenzweig, E.B., Badesch, D.B., Lanzkron, S., Castro, O., Goldsmith, J.C., Gordeuk, V. & Gladwin, M.T. (2013) The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica, 98, 464-472.
11. Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., Chora, A., Rodrigues, C.D., Gregoire, I.P., Cunha-Rodrigues, M., Portugal, S., Soares, M.P. & Mota, M.M. (2007) Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nature Medicine, 13, 703-710.
12. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease. Rates and risk factors. New England Journal of Medicine, 325, 11-16.
13. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, R.O. 3rd, Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383-1389.
14. Seixas, E., Gozzelino, R., Chora, A., Ferreira, A., Silva, G., Larsen, R., Rebelo, S., Penido, C., Smith, N.R., Coutinho, A. & Soares, M.P. (2009) Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proceedings National Academy Science of USA, 106, 15837-15842.